CRWD market-structure snapshot

$CRWD: multi-source stock research

CROWDSTRIKE HOLDINGS, INC.

MARKET STRUCTURE

Latest close on July 28, 2026: $183.38 (+1.8% on the latest daily bar).

HMA21 / HMA55: $186.67 / $200.21. 200DMA: $131.77.

Relative volume: 0.58x the 20-day average.

Nearest support/watch zone: $181.00.

Nearest resistance/watch zone: $184.66.

Price is above the 200DMA, so the long-term trend reference is supportive.

FUNDAMENTALS AND VALUATION

Latest comparable filing period: 2027 Q1 ending 2026-04-30; filed 2026-06-04.

Comparable growth: revenue +25.6% YoY; net income -126.6% YoY; diluted EPS -126.2% YoY.

Quality and cash conversion: net margin 2.0% (+1145 bp YoY); quarterly SEC free-cash-flow proxy $493.31M (+65.3% YoY).

Valuation snapshot: forward P/E 117.4x; EV/EBITDA 3029.5x; P/S 36.7x.

Read-through:
• Revenue growth did not convert into net-income growth in the comparable period.
• Cash generation improved versus the comparable period.

RECENT INSTITUTIONAL RESEARCH

• 2026-07-23 — Hugging Face was attacked by an advanced LLM proxy, exposing the shortcomings of traditional security solutions and benefiting XDR+SOAR (Morgan Stanley)

The Morgan Stanley report pointed out that Hugging Face encountered a complex security attack launched by an advanced LLM autonomous agent, and the attacker exploited the vulnerability to achieve code execution and lateral movement.

This incident exposed the limitations of traditional SIEM/XDR solutions, and Hugging Face itself successfully defended it through an LLM-based anomaly detection pipeline.

BOTTOM LINE

The technical structure is mixed, while the latest comparable period showed revenue growth but weaker profit conversion. The next confirmation must come from both price structure and the next reported operating data—not from narrative alone.

WHAT TO WATCH

• A reclaim of HMA21 near $186.67 would be the first meaningful stabilization signal.
• A close below the nearby support zone around $181.00 would weaken the setup.
• Whether the next filing confirms that revenue growth is converting into net income, EPS and cash flow.
• Whether the operating milestones identified in recent institutional research become measurable disclosures.

Research and technical observation only; not a trade recommendation.

#Stocks #Fundamentals #TechnicalAnalysis #CRWD